| Item Type | Name |
|
Academic Article
|
Terminal effects of ethanol on dopamine dynamics in rat nucleus accumbens: an in vitro voltammetric study.
|
|
Academic Article
|
Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation.
|
|
Academic Article
|
Local effects of acute ethanol on dopamine neurotransmission in the ventral striatum in C57BL/6 mice.
|
|
Academic Article
|
Short-acting cocaine and long-acting GBR-12909 both elicit rapid dopamine uptake inhibition following intravenous delivery.
|
|
Academic Article
|
Direct and indirect 5-HT receptor agonists produce gender-specific effects on locomotor and vertical activities in C57 BL/6J mice.
|
|
Academic Article
|
Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection.
|
|
Academic Article
|
Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
|
|
Academic Article
|
Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.
|
|
Academic Article
|
Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration.
|
|
Academic Article
|
Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration.
|
|
Academic Article
|
Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.
|
|
Academic Article
|
Effects of the histamine H1 receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.
|
|
Concept
|
Antidepressive Agents, Second-Generation
|
|
Concept
|
Receptors, Dopamine D3
|
|
Concept
|
Receptor, Adenosine A2A
|
|
Concept
|
Membrane Glycoproteins
|
|
Concept
|
Amphetamines
|
|
Concept
|
Receptors, Dopamine D2
|
|
Concept
|
Membrane Transport Proteins
|
|
Concept
|
KCNQ Potassium Channels
|
|
Concept
|
Nicotinic Agonists
|
|
Concept
|
Ethylnitrosourea
|
|
Concept
|
Quinpirole
|
|
Concept
|
Fluoxetine
|
|
Concept
|
Blood Glucose
|
|
Concept
|
Acetylcholine
|
|
Concept
|
Receptors, Tumor Necrosis Factor, Member 25
|
|
Concept
|
Monoamine Oxidase
|
|
Concept
|
Norepinephrine
|
|
Concept
|
Histamine H1 Antagonists
|
|
Concept
|
Histone Deacetylase Inhibitors
|
|
Concept
|
Methylphenidate
|
|
Concept
|
Cocaine
|
|
Concept
|
Phenanthridines
|
|
Concept
|
Potassium Channel Blockers
|
|
Concept
|
Levodopa
|
|
Concept
|
Amino Acids
|
|
Concept
|
Carrier Proteins
|
|
Concept
|
Biogenic Monoamines
|
|
Concept
|
Serotonin Agents
|
|
Concept
|
Receptors, G-Protein-Coupled
|
|
Concept
|
Pyrrolidines
|
|
Concept
|
G-Protein-Coupled Receptor Kinase 2
|
|
Concept
|
Calcium
|
|
Concept
|
Receptors, Neuropeptide
|
|
Concept
|
Central Nervous System Depressants
|
|
Concept
|
Receptors, Serotonin
|
|
Concept
|
Analgesics, Opioid
|
|
Concept
|
C-Reactive Protein
|
|
Concept
|
Bupropion
|
|
Concept
|
Injections, Subcutaneous
|
|
Concept
|
Urea
|
|
Concept
|
Adrenergic Uptake Inhibitors
|
|
Concept
|
Dynorphins
|
|
Concept
|
Benzoxazoles
|
|
Concept
|
Serotonin Uptake Inhibitors
|
|
Concept
|
Triazoles
|
|
Concept
|
Drug Interactions
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
|
Concept
|
Dopamine Antagonists
|
|
Concept
|
4-Aminopyridine
|
|
Concept
|
Tritium
|
|
Concept
|
Receptors, Metabotropic Glutamate
|
|
Concept
|
Propanolamines
|
|
Concept
|
gamma-Aminobutyric Acid
|
|
Concept
|
Histone Deacetylases
|
|
Concept
|
Dopamine
|
|
Concept
|
Sertraline
|
|
Concept
|
Tropanes
|
|
Concept
|
Insecticides
|
|
Concept
|
Tetrodotoxin
|
|
Concept
|
Pyridones
|
|
Concept
|
Receptors, Nicotinic
|
|
Concept
|
Receptors, Histamine H1
|
|
Concept
|
Nomifensine
|
|
Concept
|
Neurotransmitter Uptake Inhibitors
|
|
Concept
|
Receptor, Insulin
|
|
Concept
|
Injections, Intraperitoneal
|
|
Concept
|
Dopamine Uptake Inhibitors
|
|
Concept
|
Drug Synergism
|
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
|
Concept
|
Nicotinic Antagonists
|
|
Concept
|
Drug Administration Routes
|
|
Concept
|
Dopamine Agonists
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Phenmetrazine
|
|
Concept
|
Naltrexone
|
|
Concept
|
Piperazines
|
|
Concept
|
Insulin
|
|
Concept
|
Receptors, Opioid, kappa
|
|
Concept
|
Phenethylamines
|
|
Concept
|
3,4-Dihydroxyphenylacetic Acid
|
|
Concept
|
Norepinephrine Plasma Membrane Transport Proteins
|
|
Concept
|
Drug Administration Schedule
|
|
Concept
|
Autoreceptors
|
|
Concept
|
Central Nervous System Stimulants
|
|
Concept
|
Nicotine
|
|
Concept
|
Androstadienes
|
|
Concept
|
Homovanillic Acid
|
|
Concept
|
Prolactin
|
|
Concept
|
Dopamine Agents
|
|
Concept
|
Membrane Transport Modulators
|
|
Concept
|
Drug Tolerance
|
|
Concept
|
Receptors, Dopamine
|
|
Concept
|
Tetrahydroisoquinolines
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Histone Deacetylase 1
|
|
Concept
|
Mecamylamine
|
|
Concept
|
Narcotic Antagonists
|
|
Concept
|
Hypoglycemic Agents
|
|
Concept
|
Alcohol Deterrents
|
|
Concept
|
Benzimidazoles
|
|
Concept
|
Indoles
|
|
Concept
|
Tetrabenazine
|
|
Concept
|
Vesicular Monoamine Transport Proteins
|
|
Concept
|
Serotonin
|
|
Concept
|
Benztropine
|
|
Concept
|
Pesticides
|
|
Concept
|
Pyrethrins
|
|
Concept
|
Neuropeptides
|
|
Concept
|
Ethanol
|
|
Concept
|
Benzeneacetamides
|
|
Concept
|
Nitriles
|
|
Concept
|
Receptors, N-Methyl-D-Aspartate
|
|
Concept
|
Receptors, Dopamine D1
|
|
Concept
|
Desipramine
|
|
Concept
|
RGS Proteins
|
|
Concept
|
Tyrosine 3-Monooxygenase
|
|
Concept
|
Naphthyridines
|
|
Concept
|
Symporters
|
|
Concept
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Fenfluramine
|
|
Concept
|
Raclopride
|
|
Concept
|
Phosphinic Acids
|
|
Concept
|
Apomorphine
|
|
Concept
|
Protein Isoforms
|
|
Concept
|
Piperidines
|
|
Concept
|
Anesthetics, General
|
|
Concept
|
Serine
|
|
Concept
|
Dopamine Plasma Membrane Transport Proteins
|
|
Concept
|
Histones
|
|
Concept
|
Benzazepines
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Amphetamine
|
|
Concept
|
Hydroxyindoleacetic Acid
|
|
Concept
|
Nerve Tissue Proteins
|
|
Concept
|
Injections, Intravenous
|
|
Concept
|
Antidepressive Agents
|
|
Concept
|
Brain-Derived Neurotrophic Factor
|
|
Concept
|
Glucose
|
|
Academic Article
|
Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices.
|
|
Academic Article
|
Paradoxical tolerance to cocaine after initial supersensitivity in drug-use-prone animals.
|
|
Academic Article
|
Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures.
|
|
Academic Article
|
Chronic methylphenidate administration in mice produces depressive-like behaviors and altered responses to fluoxetine.
|
|
Academic Article
|
Presynaptic dopamine modulation by stimulant self-administration.
|
|
Academic Article
|
Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter.
|
|
Academic Article
|
Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine.
|
|
Academic Article
|
Frequency-dependent effects of ethanol on dopamine release in the nucleus accumbens.
|
|
Academic Article
|
Amphetamine self-administration attenuates dopamine D2 autoreceptor function.
|
|
Academic Article
|
Biphasic mechanisms of amphetamine action at the dopamine terminal.
|
|
Academic Article
|
Protein kinase C beta regulates the D2-like dopamine autoreceptor.
|
|
Academic Article
|
A Single Amphetamine Infusion Reverses Deficits in Dopamine Nerve-Terminal Function Caused by a History of Cocaine Self-Administration.
|
|
Academic Article
|
Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.
|
|
Academic Article
|
Brief intermittent cocaine self-administration and abstinence sensitizes cocaine effects on the dopamine transporter and increases drug seeking.
|
|
Academic Article
|
Chronic intermittent ethanol exposure reduces presynaptic dopamine neurotransmission in the mouse nucleus accumbens.
|
|
Academic Article
|
Greater ethanol inhibition of presynaptic dopamine release in C57BL/6J than DBA/2J mice: Role of nicotinic acetylcholine receptors.
|
|
Academic Article
|
Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine.
|
|
Academic Article
|
Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum.
|
|
Academic Article
|
Chronic ethanol self-administration in macaques shifts dopamine feedback inhibition to predominantly D2 receptors in nucleus accumbens core.
|
|
Academic Article
|
Sertraline inhibits increases in body fat and carbohydrate dysregulation in adult female cynomolgus monkeys.
|
|
Academic Article
|
Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens.
|
|
Academic Article
|
The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine.
|
|
Academic Article
|
Switch from excitatory to inhibitory actions of ethanol on dopamine levels after chronic exposure: Role of kappa opioid receptors.
|
|
Academic Article
|
Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine.
|
|
Academic Article
|
Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.
|
|
Academic Article
|
High fat diet augments amphetamine sensitization in mice: Role of feeding pattern, obesity, and dopamine terminal changes.
|
|
Academic Article
|
Reinforcing Doses of Intravenous Cocaine Produce Only Modest Dopamine Uptake Inhibition.
|
|
Academic Article
|
Cocaine Potency at the Dopamine Transporter Tracks Discrete Motivational States During Cocaine Self-Administration.
|
|
Grant
|
Ethanol Dependence Induced Changes in Dopamine Signaling in Basolateral Amygdala
|
|
Grant
|
Animal Models of Cocaine Addiction
|
|
Grant
|
Methylphenidate, Serotonin and Dopamine Interactions
|
|
Grant
|
Dopamine Transporter Changes Following Cocaine Self-Administration
|
|
Grant
|
Voltammetry in Freely Moving Mice
|
|
Grant
|
Ethanol, NMDA Receptor and Dopamine Interactions
|
|
Grant
|
The Neurobiology of Drug Abuse
|
|
Academic Article
|
Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.
|
|
Academic Article
|
Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation.
|
|
Academic Article
|
Progress in using mouse inbred strains, consomics, and mutants to identify genes related to stress, anxiety, and alcohol phenotypes.
|
|
Academic Article
|
Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.
|
|
Academic Article
|
Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors.
|
|
Academic Article
|
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants.
|
|
Academic Article
|
Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents.
|
|
Grant
|
Biased Kappa Opioid Agonists as Non-addictive Analgesics
|
|
Academic Article
|
Modulation of striatal dopamine dynamics by cocaine self-administration and amphetamine treatment in female rats.
|
|
Academic Article
|
Measurement of Dopamine Using Fast Scan Cyclic Voltammetry in Rodent Brain Slices.
|